Curanex Pharmaceuticals CURX Income Statement (2024-2025)

NASDAQ CURX
$5.27 +5.00 (+1,851.85%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Sep2024 Dec2024 Jun2025 Sep2025 Dec2025
Operating items
Research & Development (Quarter) 0.68M2.98M
Selling, General & Administrative (Quarter) 0.09M0.07M0.06M0.27M0.79M
Other Operating Expenses (Quarter) 0.07M-0.68M
Operating Expenses (Quarter) 0.09M0.15M0.06M0.95M3.09M
Operating Income (Quarter) -0.09M-0.15M-0.06M-0.95M-3.09M
EBIT (Quarter) -0.09M-0.15M-0.06M-0.95M-3.09M
Non-operating items
Other Non Operating Income (Quarter) 0.00M0.00M403.000.00M0.02M
Net income details
EBT (Quarter) -0.09M-0.28M-0.23M-1.19M-3.09M
Profit After Tax (Quarter) -0.09M-0.15M-0.06M-0.95M-3.07M
Income from Continuing Operations (Quarter) -0.09M-0.28M-0.23M-1.19M-3.09M
Consolidated Net Income (Quarter) -0.09M-0.28M-0.23M-1.19M-3.09M
Income towards Parent Company (Quarter) -0.09M-0.28M-0.23M-1.19M-3.09M
Net Income towards Common Stockholders (Quarter) -0.09M-0.28M-0.23M-1.19M-3.09M
Additional items
EPS (Basic) (Quarter) -0.04-0.02-0.01-0.05-0.12
EPS (Diluted) (Quarter) -0.04-0.02-0.01-0.05-0.12
Shares Outstanding (Quarter) 2.40M13.26M24.00M25.60M25.50M
Shares Outstanding (Diluted) (Quarter) 2.40M13.26M24.00M25.60M25.50M
Shares Outstanding (Entity) (Quarter) 2.40M13.26M24.00M28.34M28.34M
EBITDA (Quarter) -0.09M-0.15M-0.06M-0.95M-3.09M
Interest Expenses (Quarter) 0.13M0.17M0.24M